Latest news
India Approved Its First Dengue Vaccine. Access Is Still Unwritten.
India has approved QDENGA, creating the country’s first licensed dengue-vaccine option. The scientific milestone is real. The public-health result will depend on targeting, procurement, price and two-dose delivery in the districts carrying the greatest risk.
BMI is not enough. Cardiometabolic risk is hiding in where fat lives
Cancer Progress Still Depends on Your Postcode
MS Has Learnt to Stop Inflammation. It Still Cannot Repair the Damage.
A Boot-Camp Flu Outbreak Put Pentagon Vaccine Policy to the Test.
England Moved the Vaccine Clock. The Coverage Gap Stayed Put
Resistant hypertension may need a diagnostic revolution, not just another drug
When diabetes tech fails, personalised care fails with it
IPM Brief – Issue 7 | The Gate Is the Product
AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.